About this trial
This virtual randomized controlled trial evaluates the efficacy of a prebiotic and probiotic supplement in providing relief from symptoms associated with bacterial vaginosis and yeast infections. Participants will be randomized into three groups-test product, active placebo, and excipient placebo-and will take two capsules daily for 30 days. The study will assess the effects on vaginal microbiome, symptoms of bacterial vaginosis and yeast infections, and overall vaginal health.
Eligibility criteria
Qualifiers
Women
Age 25+
Self-reported concerns symptoms associated with bacterial vaginosis or candida overgrowth, including itchiness, redness, abnormal discharge, and an unpleasant odor.
Suffers from digestive issues, including bloating, gas, or other digestive discomfort.
Disqualifiers
Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
Planning to undergo any procedure related to their vaginal health.
Started any new medications or supplements that target vaginal health in the past 3 months.
Anyone with known severe allergic reactions that require the use of an Epi-Pen, or any known allergies to any of the product ingredients
Trial design
Treatments tested in this trial
- Prebiotic + Probiotic Supplement
- Active Placebo Supplement
- Excipient Placebo Supplement
Treatment groups
Sponsors and collaborators
Happy V
Lead sponsor
Citruslabs
Collaborator